Skip to Main Content

Author Details

Janine Senz
University of British Columbia
1994
81
46
PMIDPaper TitleJournal TitlePublished Year
37874327Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.Cancer Res2024
37874327Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.Cancer Res2024
36828360Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.Mod Pathol2023
37580913Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.Histopathology2023
36828360Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.Mod Pathol2023
37321155Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.Gynecol Oncol2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
36853783p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk.Mod Pathol2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
37494476Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.Cancer Res2023
36977195KRAS mutations and endometriosis burden of disease.J Pathol Clin Res2023
37580913Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.Histopathology2023
37494476Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.Cancer Res2023
37321155Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.Gynecol Oncol2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
36977195KRAS mutations and endometriosis burden of disease.J Pathol Clin Res2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
36853783p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk.Mod Pathol2023
34497363Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status.Mod Pathol2022
35715244Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.Fertil Steril2022
36100281Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma.Int J Gynecol Cancer2022
35764349Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.Int J Gynecol Cancer2022
34497363Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status.Mod Pathol2022
35764349Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.Int J Gynecol Cancer2022
35715244Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.Fertil Steril2022
36100281Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma.Int J Gynecol Cancer2022
32895333Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis.Gut2021
32066632Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.J Med Genet2021
32895333Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis.Gut2021
33428330Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.J Pathol Clin Res2021
32066632Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.J Med Genet2021
33428330Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.J Pathol Clin Res2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32737030Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.Clin Cancer Res2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32737030Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.Clin Cancer Res2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
30922603Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.Gynecol Oncol2019
30986800DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.Am J Surg Pathol2019
30922603Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.Gynecol Oncol2019
30986800DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.Am J Surg Pathol2019
29148539Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.Mod Pathol2018
29660837DICER1 hot-spot mutations in ovarian gynandroblastoma.Histopathology2018
29148539Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.Mod Pathol2018
29660837DICER1 hot-spot mutations in ovarian gynandroblastoma.Histopathology2018
28061006Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.Cancer2017
28489996Cancer-Associated Mutations in Endometriosis without Cancer.N Engl J Med2017
28746984Identical TP53 mutations provide evidence that late-recurring tubo-ovarian high-grade serous carcinomas do not represent new peritoneal primaries.Histopathology2017
29032825LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers.Gynecol Oncol2017
  • 1 - 50 of 162

Recommended Authors

David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 3
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 10
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 7
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 16
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 12
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 5
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 40
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Career Start Year 2004
Number of shared co-authors 30
Rebecca Nagy
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 1
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 0
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 34
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 4
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 16
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 13
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 87
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 20
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 59
Rebecca Sutphen
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 87
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 5
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 33
Aaron Pollett
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 13
Tanja Pejovic
Oregon Health & Science University
Career Start Year 1989
Number of shared co-authors 116
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 10
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 15
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 65
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 18
Ronny Drapkin
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 68
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 5
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 103

Collaborators

David G Huntsman
University of British Columbia
Co-authored papers 69
Cyril B Gilks
University of British Columbia
Co-authored papers 43
Michael S Anglesio
University of British Columbia
Co-authored papers 27
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Co-authored papers 21
Amy Lum
University of British Columbia
Co-authored papers 15
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Co-authored papers 14
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 14
Pardeep Kaurah
University of British Columbia
Co-authored papers 13
Marco A Marra
University of British Columbia
Co-authored papers 12
Samuel Leung
University of British Columbia
Co-authored papers 11
Steve E Kalloger
University of British Columbia
Co-authored papers 11
Aline Talhouk
The University of British Columbia
Co-authored papers 11
Martin Hirst
University of British Columbia
Co-authored papers 10
Martin K??bel
University of Calgary
Co-authored papers 10
Ali Bashashati
University of British Columbia
Co-authored papers 9
Alireza Heravi-Moussavi
Ferdowsi University of Mashhad
Co-authored papers 8
Samuel Aparicio
University of British Columbia
Co-authored papers 8
Kasmintan A Schrader
University of British Columbia
Co-authored papers 8
Carla Oliveira
Co-authored papers 8
Tayyebeh M Nazeran
University of British Columbia
Co-authored papers 7
Robertson Mackenzie
Vancouver General Hospital, and University of British Columbia
Co-authored papers 7
Derek S Chiu
University of British Columbia, and Vancouver General Hospital
Co-authored papers 6
Naveena Singh
Barts Health NHS Trust
Co-authored papers 6
Richard A Moore
Co-authored papers 6
Steven J M Jones
University of British Columbia
Co-authored papers 5
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 5
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 4
Samantha Hansford
The University of British Columbia
Co-authored papers 4
F??tima Carneiro
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 4
Release 1.2